These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2551389

  • 21. A search for an 'ouabain-like' substance from the electric organ of Electrophorus electricus which led to arachidonic acid and related fatty acids.
    Bidard JN, Rossi B, Renaud JF, Lazdunski M.
    Biochim Biophys Acta; 1984 Jan 11; 769(1):245-52. PubMed ID: 6318825
    [Abstract] [Full Text] [Related]

  • 22. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis.
    Zhao N, Lo LC, Berova N, Nakanishi K, Tymiak AA, Ludens JH, Haupert GT.
    Biochemistry; 1995 Aug 08; 34(31):9893-6. PubMed ID: 7632688
    [Abstract] [Full Text] [Related]

  • 23. Solubilization and further chromatographic purification of highly purified, membrane-bound Na,K-ATPase.
    Ottolenghi P, Nørby JG, Jensen J.
    Biochem Biophys Res Commun; 1986 Mar 28; 135(3):1008-14. PubMed ID: 3008735
    [Abstract] [Full Text] [Related]

  • 24. Studies on ouabain-like endogenous natriuretic factors in human urine. Inhibition of Na-K-ATPase and 3H-ouabain binding.
    Kramer HJ, Baecker A, Weiler E, Liddiard C.
    Klin Wochenschr; 1986 Aug 15; 64(16):760-6. PubMed ID: 3020314
    [Abstract] [Full Text] [Related]

  • 25. Purification and characterization of specific endogenous ouabainlike substance from bovine adrenal.
    Inagami T, Tamura M.
    Am J Med Sci; 1988 Apr 15; 295(4):400-5. PubMed ID: 2834953
    [Abstract] [Full Text] [Related]

  • 26. Characterization of digitalis-like factors in human plasma. Interactions with NaK-ATPase and cross-reactivity with cardiac glycoside-specific antibodies.
    Kelly RA, O'Hara DS, Canessa ML, Mitch WE, Smith TW.
    J Biol Chem; 1985 Sep 25; 260(21):11396-405. PubMed ID: 2995332
    [Abstract] [Full Text] [Related]

  • 27. Ouabain-binding site of (Na+ + K+)-ATPase in right-side-out vesicles has not an externally accessible SH group.
    Scheiner-Bobis G, Zimmermann M, Kirch U, Schoner W.
    Eur J Biochem; 1987 Jun 15; 165(3):653-6. PubMed ID: 3036511
    [Abstract] [Full Text] [Related]

  • 28. Na,K-ATPase inhibitor from guinea pig brain is not ouabain-like.
    Kracke GR.
    J Lab Clin Med; 1983 Jan 15; 101(1):105-13. PubMed ID: 6294201
    [Abstract] [Full Text] [Related]

  • 29. A non-ouabain Na/K ATPase inhibitor isolated from bovine hypothalamus. Its relation to hypothalamic ouabain.
    Sancho JM.
    Clin Exp Hypertens; 1998 Jan 15; 20(5-6):535-42. PubMed ID: 9682909
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF, Crabos M, Grichois ML, Guicheney P, Meyer P.
    Klin Wochenschr; 1987 Jan 15; 65 Suppl 8():146-53. PubMed ID: 3037183
    [Abstract] [Full Text] [Related]

  • 35. [The calixarenes C-97 and C-107 stimulate influence of ouabain on the Na+,K+-ATPase activity in plasmatic membrane of smooth muscle cells].
    Veklich TO, Shkrabak OA, Kosterin SO, Rodik RV, Cherenok SO, Boĭko SO, Boĭko VI, Kal'chenko VI.
    Ukr Biokhim Zh (1999); 2006 Jan 15; 78(6):53-63. PubMed ID: 17494319
    [Abstract] [Full Text] [Related]

  • 36. Ascorbic acid: an endogenous inhibitor of isolated Na+,K+-ATPase.
    Ng YC, Akera T, Han CS, Braselton WE, Kennedy RH, Temma K, Brody TM, Sato PH.
    Biochem Pharmacol; 1985 Jul 15; 34(14):2525-30. PubMed ID: 2990490
    [Abstract] [Full Text] [Related]

  • 37. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na+,K+-ATPase (α1β1): Methodological considerations.
    Noël F, Azalim P, do Monte FM, Quintas LEM, Katz A, Karlish SJD.
    J Pharmacol Toxicol Methods; 2018 Jul 15; 94(Pt 2):64-72. PubMed ID: 30244071
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM, Rey HG, Moosmayer M, Meszoely I, Haupert GT.
    Am J Physiol; 1990 Jan 15; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.